GDNF gene therapy: potent benefits in Parkinson's disease?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1266, 2000-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pramipexole for initial therapy of early Parkinson's disease?

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Chaperone therapy: protective against Parkinson's disease?

Inpharma, Vol. 1, Iss. 1326, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

When Should Levodopa Therapy be Initiated in Patients with Parkinson's Disease?

By Halkias Irene A.C. Haq Ihtsham Huang Zhigao Fernandez Hubert H.

Drugs & Aging, Vol. 24, Iss. 4, 2007-01 ,pp. : 261-273

Adis International

Access to resources Recommend Favorite

Pramipexole: treatment of choice in early Parkinson's disease?

Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Does Levodopa Accelerate Parkinson's Disease?

By Simuni T. Stern M.B.

Drugs & Aging, Vol. 14, Iss. 6, 1999-06 ,pp. : 399-408

Adis International

Access to resources Recommend Favorite